Vital Signs - Breast Screening in the Wake of Expanding Breast Density Reporting Laws in the United States

 

Regular Price: USD 1,500

Special Price USD 1,125

25% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,125

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on November 23, 2012, provides an insight in to breast screening against the backdrop of the recent changes in breast density reporting laws in the United States.

Additionally, a company spotlight is provided for MinXray. Founded in 1967, MinXray, Inc. is a worldwide provider of transportable x-ray imaging equipment for medical, veterinary, dental, military, security, disaster response and forensics applications. Reimbursement and regulatory news from the FDA is also provided for week of October 22, 2012.

Table of Contents

Vital Signs - Breast Screening in the Wake of Expanding Breast Density Reporting Laws in the United StatesVital Signs: 23 November 2012This week's issue




Related Research

Release Date : 26-Sep-17

Region : North America

Release Date : 25-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.